What is Ibrutinib 140 Mg?
Ibrutinib 140 Mg is a prescription medication manufactured by Hetero Drugs Ltd, formulated to treat certain types of blood cancers. It contains the active ingredient Ibrutinib, which belongs to a class of drugs known as Bruton's tyrosine kinase (BTK) inhibitors. This medication has been extensively studied and is widely recognized for its role in managing mantle-cell lymphoma and chronic lymphocytic leukemia, providing patients with an important therapeutic option.
Developed with precision to target cancer cell pathways, Ibrutinib 140 Mg offers a targeted approach to treatment rather than traditional chemotherapy. It works by interfering with the signals that promote the growth and survival of malignant cells, thereby helping to control disease progression. This mode of action minimizes damage to healthy cells compared to conventional treatments.
Prescribed under medical supervision, Ibrutinib is taken orally and has become a crucial component in modern oncology practices for blood cancer patients. The approval and usage in countries like Malaysia have made it accessible to those in need, ensuring effective cancer management through innovative therapies.
Uses of Ibrutinib 140 Mg
- Treatment of mantle-cell lymphoma (MCL)
- Management of chronic lymphocytic leukemia (CLL)
- Used in patients with specific genetic markers indicating suitability for BTK inhibitor therapy
- Management of relapsed or refractory blood cancers
How Ibrutinib 140 Mg Works
Ibrutinib 140 Mg functions by selectively inhibiting Bruton's tyrosine kinase (BTK), an enzyme that plays a key role in the proliferation and survival of malignant B-cells. By blocking BTK, the drug interrupts signaling pathways that promote cancer cell growth and survival. This targeted mechanism reduces tumor progression and helps the immune system control the cancer more effectively.
The inhibition of BTK also affects the microenvironment that supports cancer cells, reducing their ability to multiply and spread. This precise action provides a more focused treatment approach with fewer adverse effects compared to traditional chemotherapy.
How to take Ibrutinib 140 Mg
Take Ibrutinib 140 Mg exactly as prescribed by your healthcare provider. The medication is usually taken orally once daily, with or without food. Do not crush, chew, or break the tablets; swallow them whole.
It is important to take the medication at the same time each day to maintain consistent levels in your bloodstream. Do not alter your dose or discontinue use without consulting your doctor, even if you feel well.
Benefits of Ibrutinib 140 Mg
- Targets cancer cells specifically, reducing damage to healthy cells
- Oral administration offers convenience over intravenous therapies
- Effective in managing mantle-cell lymphoma and chronic lymphocytic leukemia
- Improves progression-free survival in eligible patients
- Provides an option for patients with relapsed or refractory blood cancers
- Generally well tolerated with manageable side effects
Dosage and Administration
The recommended dose of Ibrutinib 140 Mg varies depending on the condition treated. For mantle-cell lymphoma, typical dosing is 560 mg once daily, often administered as four tablets of 140 mg each. For chronic lymphocytic leukemia, dosing may differ based on individual patient factors and disease severity.
Always follow your doctor’s instructions carefully. Regular monitoring through blood tests and clinical evaluations is essential to adjust the dose if necessary and to track treatment effectiveness.
Who Should Use Ibrutinib 140 Mg?
Ibrutinib 140 Mg is intended for patients diagnosed with mantle-cell lymphoma and chronic lymphocytic leukemia, particularly those who have relapsed or are refractory to previous treatments. It is suitable for adults whose medical profile aligns with BTK inhibitor therapy as determined by their hematologist or oncologist.
Who Should Avoid Ibrutinib 140 Mg?
Patients with known hypersensitivity to Ibrutinib or any component of the medication should avoid use. Additionally, caution is advised in patients with bleeding disorders or those taking anticoagulants due to increased bleeding risk. Pregnant or breastfeeding women should not use Ibrutinib unless advised by a healthcare professional after thorough risk assessment.
Side Effects of Ibrutinib 140 Mg
- Diarrhea
- Nausea
- Fatigue
- Upper respiratory tract infections
- Bruising or bleeding
- Muscle or joint pain
- Low platelet counts
- Anemia
- Rash
- Shortness of breath
Safety Advice
- Inform your doctor about all medications and supplements you are taking
- Report any unusual bleeding or bruising immediately
- Avoid activities with a high risk of injury during treatment
- Regularly monitor blood counts as advised by your clinician
- Do not stop medication without consulting your healthcare provider
- Discuss any history of infections or chronic illnesses with your doctor before starting treatment
Drug Interactions
- Anticoagulants and antiplatelet drugs may increase bleeding risk
- Strong CYP3A inhibitors or inducers can affect Ibrutinib metabolism
- Medications metabolized by CYP3A enzymes require caution
- Consult your healthcare provider before combining with other treatments
Storage Instructions
Store Ibrutinib 140 Mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use the medication past its expiration date. Follow any additional storage recommendations listed on the packaging or by your pharmacist.
Where to buy Ibrutinib 140 Mg in Malaysia?
Ibrutinib 140 Mg is available through licensed pharmacies and authorized medical suppliers in Malaysia. Due to its prescription-only status, patients must obtain this medication with a valid prescription from an oncologist or hematologist. Purchasing from reputable sources ensures product authenticity and safety.
Frequently Asked Questions (FAQ)
What is the price of Ibrutinib 140 Mg in Malaysia?
The price of Ibrutinib 140 Mg in Malaysia varies by supplier and pharmacy. It is advisable to consult your healthcare provider or authorized pharmacies for current pricing and insurance coverage options.
What happens if I miss a dose?
If you miss a dose of Ibrutinib 140 Mg, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one. Contact your healthcare provider for guidance if unsure.
Where can I find Ibrutinib 140 Mg for sale?
You can find Ibrutinib 140 Mg at licensed pharmacies and medical centers in Malaysia with a valid prescription. Avoid unauthorized sellers to ensure safety and authenticity.
Is Ibrutinib 140 Mg available in Malaysia?
Yes, Ibrutinib 140 Mg is available in Malaysia through prescription at authorized healthcare facilities and pharmacies.
Can I take Ibrutinib 140 Mg with other medications?
Some medications may interact with Ibrutinib 140 Mg. Always inform your doctor about all medicines you are taking to avoid potential drug interactions.
How long will I need to take Ibrutinib 140 Mg?
The duration of treatment varies depending on your condition and response to therapy. Your healthcare provider will determine the appropriate length of use based on your progress.
Are there any dietary restrictions while taking Ibrutinib 140 Mg?
No specific dietary restrictions are generally required, but maintaining a healthy diet and consulting your doctor about any supplements is recommended.
Conclusion
Ibrutinib 140 Mg is a powerful and targeted therapy for patients suffering from mantle-cell lymphoma and chronic lymphocytic leukemia. Produced by Hetero Drugs Ltd, it offers a well-tolerated treatment option that works by specifically inhibiting BTK to control cancer cell growth. With appropriate medical supervision, Ibrutinib 140 Mg can improve disease management and patient quality of life. Always consult your healthcare professional to determine if this medication is suitable for you and to ensure safe and effective treatment.
Leave A Review